Prompt- Create a super aesthetic, handwritten-style revision note page for the topic: • Make it look like neat exam notes written on a page (top view, clean layout, colorful headings, underlines, boxes). • Keep it crisp, high-yield, and exam-oriented. • Use clear headings and organize content like this (modify if needed for topic): ○ Definition ○ Etiology ○ Pathogenesis (flow/arrow style) ○ Clinical features ○ Radiographic features (if applicable) ○ Histopathology (if applicable) ○ Key features ○ Differential diagnosis ○ Management ○ Complications ○ Key points / last-minute revision box • Add simple diagrams or labeled sketches wherever helpful. • Highlight important keywords. • Include one memory trick / one-line summary •
acute pancreatitis etiology pathogenesis clinical features management high yield exam notes

Pph management,treatment details,dosage,contraindication
postpartum hemorrhage PPH management drugs dosage oxytocin misoprostol tranexamic acid carboprost 2024 guidelines
PPH drugs dosage contraindications management steps

| Cause | % |
|---|---|
| Tone (uterine atony) | 70% |
| Trauma (lacerations) | 19% |
| Tissue (retained placenta) | 10% |
| Thrombin (coagulopathy) | 1% |
| Drug | Dose | Contraindications |
|---|---|---|
| Oxytocin (1st line) | 10 IU IM/slow IV; 40 IU in 500 mL infusion | Rapid IV → hypotension |
| Ergometrine | 500 mcg IM or 250 mcg IV slowly | Hypertension, pre-eclampsia, cardiac disease |
| Syntometrine | 1 mL IM | Hypertension, cardiac disease |
| Carboprost (PGF2α) | 250 mcg IM q15 min, max 8 doses (2 mg) | ASTHMA (absolute CI), hepatic/renal disease |
| Misoprostol (PGE1) | 800-1000 mcg PR or 600-800 mcg SL | Cardiovascular disease (caution) |
| Tranexamic Acid | 1g IV over 10 min; repeat after 30 min if needed (within 3 hrs) | Thromboembolism risk (caution) |
Eclampsia management
eclampsia management magnesium sulfate antihypertensives dosage protocol 2024 guidelines
eclampsia magnesium sulfate dose contraindications toxicity antidote antihypertensives

| Protocol | Loading Dose | Maintenance |
|---|---|---|
| IV | 4–6 g in 100 mL NS over 15–20 min | 1–2 g/hr for 24 hrs after last seizure/delivery |
| IM (no IV access) | 10 g IM (5 g each buttock) | 5 g IM every 4 hrs |
| Recurrent seizure | Extra 2 g IV bolus | Increase infusion rate |
| Mg Level | Effect |
|---|---|
| 5–10 mEq/L | Loss of patellar reflexes (FIRST sign!) |
| 10–13 mEq/L | Respiratory depression |
| >15 mEq/L | Cardiac arrest |
| Drug | Dose | Contraindication |
|---|---|---|
| Labetalol (1st line) | 20 mg IV → repeat 40–80 mg q10 min; max 300 mg | Asthma, heart block, bradycardia |
| Hydralazine | 5–10 mg IV q20 min; max 30 mg | Lupus, aortic dissection |
| Nifedipine (oral) | 10–20 mg oral; repeat in 30 min | Caution with MgSO4 (additive hypotension) |
| Nicardipine | 5–15 mg/hr IV infusion | - |
1p0ml NS or 13 ml NS for 4g Mgso4
4 g ÷ 0.5 g/mL = 8 mL of 50% MgSO4
| Preparation | MgSO4 vol | Diluent | Total vol | Infuse over |
|---|---|---|---|---|
| Standard (WHO/RCOG) | 8 mL (50%) | 92 mL NS → total 100 mL | 100 mL | 15–20 min |
| Concentrated (some protocols) | 8 mL (50%) | 12 mL NS → total 20 mL | 20 mL | 10–15 min slow push |
| Pritchard IM protocol | 10 g IM (5 g each buttock) | No diluent | — | — |
| Question | Answer |
|---|---|
| Volume of 50% MgSO4 for 4 g | 8 mL |
| Standard diluent | 92 mL NS (total 100 mL) |
| "10 mL NS" correct? | ❌ No standard protocol |
| "13 mL NS" correct? | ❌ No standard protocol |
| Correct standard dilution | 8 mL MgSO4 + 92 mL NS = 100 mL total |